Hyloris Pharmaceuticals SA (EBR:HYL)

Belgium · Delayed Price · Currency is EUR

6.86

-0.28 (-3.92%)

At close: Mar 2, 2026

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals	9.76M	3.76M	2.39M	3.10M	175.00K
Pharmaceuticals Growth	159.64%	57.48%	-22.90%	1669.14%	92.31%
Total	9.76M	3.76M	2.39M	3.10M	175.00K
Total Growth	159.64%	57.48%	-22.90%	1669.14%	92.31%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
United States	5.59M	1.13M	-	-	-
United States Growth	396.71%	-	-	-	-
Belgium	-	-	-	3.10M	175.00K
Belgium Growth	-	-	-	1669.14%	92.31%
Total	5.59M	1.13M	-	3.10M	175.00K
Total Growth	396.71%	-	-	1669.14%	92.31%

Source: S&P Global Market Intelligence.